Literature DB >> 9507221

Risk of atrophy in kidneys with atherosclerotic renal artery stenosis.

M T Caps1, R E Zierler, N L Polissar, R O Bergelin, K W Beach, K Cantwell-Gab, A Casadei, R C Davidson, D E Strandness.   

Abstract

The goal of this study was to determine the incidence of and risk factors for renal atrophy among kidneys with atherosclerotic renal artery stenosis (ARAS). Participants with at least one ARAS were followed prospectively with duplex scans performed every six months. Renal atrophy was defined as a reduction in renal length of greater than 1 cm. A total of 204 kidneys in 122 subjects were followed for a mean of 33 months. The two-year cumulative incidence (CI) of renal atrophy was 5.5%, 11.7%, and 20.8% in kidneys with a baseline renal artery disease classification of normal, <60% stenosis, and > or = 60% stenosis, respectively (P = 0.009, log rank test). Other baseline factors associated with a high risk of renal atrophy included a systolic blood pressure > 180 mm Hg (2-year CL = 35%, P = 0.01), a renal artery peak systolic velocity > 400 cm/second (2-year CI = 32%, P = 0.02), and a renal cortical end diastolic velocity < or = 5 cm/second (2-year CI = 29%, P = 0.046). The number of kidneys demonstrating atrophy per participant was correlated with elevations in the serum creatinine concentration (P = 0.03). In patients with ARAS, there is a significant risk of renal atrophy among kidneys exposed to elevated systolic blood pressure and among those with high-grade ARAS and low renal cortical blood flow velocity as assessed by renal duplex scanning. The occurrence of renal atrophy is well-correlated with changes in the serum creatinine concentration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507221     DOI: 10.1046/j.1523-1755.1998.00805.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  38 in total

Review 1.  Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention.

Authors:  R G Woolfson
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

2.  Renal Artery Stenosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-06

Review 3.  Management of atherosclerotic renovascular disease: the effect of renal artery stenting on renal function and blood pressure.

Authors:  Kosmas I Paraskevas; Despina Perrea; Despina D Briana; Christos D Liapis
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

4.  Revascularization in a 17-Year-Old Girl with Neurofibromatosis and Severe Hypertension Caused by Renal Artery Stenosis.

Authors:  Carmen C Beladan; Oliviana D Geavlete; Simona Botezatu; Marin Postu; Bogdan A Popescu; Carmen Ginghina; Ioan M Coman
Journal:  Tex Heart Inst J       Date:  2017-02-01

5.  Ultrasound Contrast Agents in the Study of Kidney Function in Health and Disease.

Authors:  Kambiz Kalantarinia; Mark D Okusa
Journal:  Drug Discov Today Dis Mech       Date:  2007

Review 6.  Atherosclerotic renal artery stenosis: surgery, percutaneous transluminal angioplasty, or medical therapy?

Authors:  P F Plouin; B Guéry; A La Batide Alanore
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

7.  Ultrasound Assessment of Kidney Volume in Patients with Acute Decompensated Heart Failure: A Predictor of Diuretic Resistance.

Authors:  Shinobu Sugihara; Yoshiharu Kinugasa; Tomoaki Takata; Takaaki Sugihara; Keiko Hosho; Chitose Imai; Hiromi Ito; Kensaku Yamada; Masahiko Kato; Kazuhiro Yamamoto
Journal:  Yonago Acta Med       Date:  2017-09-15       Impact factor: 1.641

8.  Atherosclerotic Renal Artery Stenosis.

Authors:  Robert D. Safian
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-04

Review 9.  Clinical practice. Renal-artery stenosis.

Authors:  Lance D Dworkin; Christopher J Cooper
Journal:  N Engl J Med       Date:  2009-11-12       Impact factor: 91.245

10.  Normal kidney size and its influencing factors - a 64-slice MDCT study of 1.040 asymptomatic patients.

Authors:  Bernhard Glodny; Verena Unterholzner; Bernadette Taferner; Karin J Hofmann; Peter Rehder; Alexander Strasak; Johannes Petersen
Journal:  BMC Urol       Date:  2009-12-23       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.